Ghofrani H, Simonneau G, D'Armini AM, et al. Efficacy and Safety of Macitentan for Inoperable Chronic Thromboembolic Pulmonary Hypertension: Results from the Randomized Controlled MERIT Study. ATS 2017, A7601.
Voordeel van pembrolizumab vs. chemotherapie ook bij lage PD-L1-expressie
mei 2019